• Member Login
  • Become a Member
  • Database Search
IATI - Israel Advanced Technology Industries
IATI - Israel Advanced Technology Industries
IATI Database Life Science Companies Biotechnology BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

BrainStorm Cell Therapeutics

IATI Member

Website: http://www.brainstorm-cell.com

Category: Biotechnology
Sub-category: Tissue Engineering & Cell Therapy
Est.: 2004
Stage: Clinical

BrainStorm Cell Therapeutics is a leading developer of innovative autologous adult stem cell therapeutics for debilitating neurodegenerative diseases. BrainStorm has developed a proprietary process for inducing autologous Mesenchymal Stem Cells (MSC) to differentiate into neurotrophic factor (NTF) secreting cells (MSC-NTF cells; NurOwn®) while maintaining the important immunomodulatory capacities of the MSC cell.

BrainStorm is currently enrolling a Phase 3 pivotal trial in Amyotrophic Lateral Sclerosis (ALS NCT03280056), investigating repeat-administration of autologous MSC-NTF cells and has initiated a Phase 2 open-label multicenter trial in progressive Multiple Sclerosis.

Contact Person Chaim Lebovits, CEO
General Email uri@brainstorm-cell.com
Address Rehov Basel 12, Peatch Tikva
Phone 039236384
Fax 039236385

To update your company data, click here.
| Terms of Use | Privacy Policy | Sitemap